Home » Medical » Ability to Conduct Human Trials Gives Synchron the Edge in BCI MarketMedicalAbility to Conduct Human Trials Gives Synchron the Edge in BCI Market Manny Johnson August 28, 2021 3 Views Synchron has won FDA approval for an IDE for a trial of the Stentrode Motor Prosthesis. The company was also awarded $10 million from NIH to help fund the trial.
